Rare diseases
Investigational molecules
Locations
Back to Romania322 clinical trials in Timisoara, Romania across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RomaniaRomaniaRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
RomaniaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
RomaniaPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
RomaniaBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
RomaniaZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
RomaniaStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
RomaniaStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
RomaniaA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
RomaniaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
RomaniaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on pulmonary conditions including investigations of new treatments for idiopathic pulmonary fibrosis and uncontrolled asthma. Research includes evaluation of novel antibody therapies and assessment of respiratory function markers.
Comprehensive research into various cancer types, with particular emphasis on lung cancer and breast cancer treatments. Studies evaluate novel combination therapies and targeted treatments for specific genetic mutations.
Clinical investigations targeting inflammatory diseases including studies on ulcerative colitis, Crohn's disease, and Sjögren's disease. Research focuses on evaluating long-term safety and efficacy of innovative biological therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
